RMP-7 permeation enhancer for carboplatin data

ALKS reported preliminary results of a Phase II open-label trial of RMP-7 with carboplatin in 50 patients

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE